02587nam 2200577 a 450 991082376960332120240313103228.01-118-35680-21-283-89332-01-118-35678-0(CKB)2550000000710765(EBL)1098891(OCoLC)794306445(SSID)ssj0000784062(PQKBManifestationID)11428760(PQKBTitleCode)TC0000784062(PQKB)11243278(MiAaPQ)EBC1098891(Au-PeEL)EBL1098891(CaPaEBR)ebr10639275(CaONFJC)MIL420582(PPN)178889687(EXLCZ)99255000000071076520120522d2013 uy 0engur|n|---|||||txtccrProduction of plasma proteins for therapeutic use /edited by Joseph Bertolini, Neil Goss, John Curling1st ed.Hoboken, N.J. John Wiley & Sonsc20131 online resource (510 p.)Description based upon print version of record.0-470-92431-4 Includes bibliographical references and index.section 1. Introduction to plasma fractionation -- section 2. Plasma proteins for therapeutic use -- section 3. Pathogen safety of plasma products -- section 4. The pharmaceutical environment applied to plasma fractionation -- section 5. The market for plasma products and the economics of fractionation.Sets forth the state of the science and technology in plasma protein production With contributions from an international team of eighty leading experts and pioneers in the field, Production of Plasma Proteins for Therapeutic Use presents a comprehensive overview of the current state of knowledge about the function, use, and production of blood plasma proteins. In addition to details of the operational requirements for the production of plasma derivatives, the book describes the biology, development, research, manufacture, and clinical indications of essentially alBlood proteinsTherapeutic useBlood proteinsTherapeutic use.615.3/9Bertolini Joseph1724334Goss Neil1724335Curling J. M(John M.)1724336MiAaPQMiAaPQMiAaPQBOOK9910823769603321Production of plasma proteins for therapeutic use4126388UNINA